CSNpharm
Ribavirin blocks nucleic acid synthesis and inhibits both RNA and DNA viruses. Ribavirin is a nucleoside antimetabolite antiviral agent.
More Information
Supplier Page
CSNpharm
Ribavirin blocks nucleic acid synthesis and inhibits both RNA and DNA viruses. Ribavirin is a nucleoside antimetabolite antiviral agent.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Riboflavin Phosphate Sodium is a nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables.
More Information
Supplier Page
CSNpharm
Riboflavin Phosphate Sodium is a nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables.
More Information
Supplier Page
CSNpharm
Riboflavin tetrabutyrate, a derivative of lipophilic flavin, has antioxidative and lipid peroxide-removing activity. It can used as adjuvant therapy for thrombus formation and atherosclerosis.
More Information
Supplier Page
CSNpharm
Ribostamycin Sulfate is a broad-spectrum antimicrobial isolated from Streptomyces ribosifidicus, which acts through binding to the bacterial 30S and 50S ribosomal subunit , inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and thus causing misreading of mRNA.
More Information
Supplier Page
CSNpharm
Rifabutin is an antibiotic used to treat tuberculosis and prevent and treat Mycobacterium avium complex, which works through inhibiting DNA-dependent RNA polymerase activity in susceptible cells.
More Information
Supplier Page
CSNpharm
Rifabutin is an antibiotic used to treat tuberculosis and prevent and treat Mycobacterium avium complex, which works through inhibiting DNA-dependent RNA polymerase activity in susceptible cells.
More Information
Supplier Page
CSNpharm
Rifabutin is an antibiotic used to treat tuberculosis and prevent and treat Mycobacterium avium complex, which works through inhibiting DNA-dependent RNA polymerase activity in susceptible cells.
More Information
Supplier Page
CSNpharm
Rifamycin sodium (Rifamycin SV monosodium) belongs to the family of ansamycin antibiotics and has been isolated from the fermentation of A. mediterranei or its mutants. Rifamycin sodium displays a broad spectrum of antibiotic activity against Gram-positive and, to a lesser extent, Gram-negative bacteria[1].
More Information
Supplier Page
CSNpharm
Rifapentine is an antibiotic compound, which inhibits DNA-dependent RNA polymerase activity, used to treat tuberculosis.
More Information
Supplier Page
CSNpharm
Rifapentine is an antibiotic compound, which inhibits DNA-dependent RNA polymerase activity, used to treat tuberculosis.
More Information
Supplier Page
CSNpharm
Rifapentine is an antibiotic compound, which inhibits DNA-dependent RNA polymerase activity, used to treat tuberculosis.
More Information
Supplier Page
CSNpharm
Rilmenidine Phosphate is an oxazole-derived agonist of adrenergic receptor α2 and Imidazoline receptor, used in trials studying the treatment of hypertension and chronic kidney disease.
More Information
Supplier Page
CSNpharm
Rilmenidine Phosphate is an oxazole-derived agonist of adrenergic receptor α2 and Imidazoline receptor, used in trials studying the treatment of hypertension and chronic kidney disease.
More Information
Supplier Page
CSNpharm
Rilmenidine Phosphate is an oxazole-derived agonist of adrenergic receptor α2 and Imidazoline receptor, used in trials studying the treatment of hypertension and chronic kidney disease.
More Information
Supplier Page
CSNpharm
Riluzole is an antagonist of glutamate that used as an anticonvulsant. It can prolong the survival of patients with amyotrophic lateral sclerosis.
More Information
Supplier Page
CSNpharm
Riluzole is an antagonist of glutamate that used as an anticonvulsant. It can prolong the survival of patients with amyotrophic lateral sclerosis.
More Information
Supplier Page
CSNpharm
Riluzole is an antagonist of glutamate that used as an anticonvulsant. It can prolong the survival of patients with amyotrophic lateral sclerosis.
More Information
Supplier Page
CSNpharm
Riluzole is an antagonist of glutamate that used as an anticonvulsant. It can prolong the survival of patients with amyotrophic lateral sclerosis.
More Information
Supplier Page
CSNpharm
Riluzole is an antagonist of glutamate that used as an anticonvulsant. It can prolong the survival of patients with amyotrophic lateral sclerosis.
More Information
Supplier Page
CSNpharm
CSNpharm
RIN1
1mg
| ≥99%
CSNpharm
RIN1 is a new class of small molecule inhibitor that disrupts the interaction between NOTCH and RBPJ. It also blocked the functional interaction of RBPJ with SHARP, a scaffold protein that forms a transcriptional repressor complex with RBPJ in the absence of NOTCH signaling.
More Information
Supplier Page
RIN1
25mg
| ≥99%
CSNpharm
RIN1 is a new class of small molecule inhibitor that disrupts the interaction between NOTCH and RBPJ. It also blocked the functional interaction of RBPJ with SHARP, a scaffold protein that forms a transcriptional repressor complex with RBPJ in the absence of NOTCH signaling.
More Information
Supplier Page
RIN1
10mg
| ≥99%
CSNpharm
RIN1 is a new class of small molecule inhibitor that disrupts the interaction between NOTCH and RBPJ. It also blocked the functional interaction of RBPJ with SHARP, a scaffold protein that forms a transcriptional repressor complex with RBPJ in the absence of NOTCH signaling.
More Information
Supplier Page
RIN1
100mg
| ≥99%
CSNpharm
RIN1 is a new class of small molecule inhibitor that disrupts the interaction between NOTCH and RBPJ. It also blocked the functional interaction of RBPJ with SHARP, a scaffold protein that forms a transcriptional repressor complex with RBPJ in the absence of NOTCH signaling.
More Information
Supplier Page
RIN1
50mg
| ≥99%
CSNpharm
RIN1 is a new class of small molecule inhibitor that disrupts the interaction between NOTCH and RBPJ. It also blocked the functional interaction of RBPJ with SHARP, a scaffold protein that forms a transcriptional repressor complex with RBPJ in the absence of NOTCH signaling.
More Information
Supplier Page
RIN1
5mg
| ≥99%
CSNpharm
RIN1 is a new class of small molecule inhibitor that disrupts the interaction between NOTCH and RBPJ. It also blocked the functional interaction of RBPJ with SHARP, a scaffold protein that forms a transcriptional repressor complex with RBPJ in the absence of NOTCH signaling.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Risperidone is a multiple-target antipsychotic with high affinity for 5-HT2A and D2 receptors, alpha 1, alpha 2 and H1 receptors.
More Information
Supplier Page
CSNpharm
Risperidone is a multiple-target antipsychotic with high affinity for 5-HT2A and D2 receptors, alpha 1, alpha 2 and H1 receptors.
More Information
Supplier Page
CSNpharm
Risperidone is a multiple-target antipsychotic with high affinity for 5-HT2A and D2 receptors, alpha 1, alpha 2 and H1 receptors.
More Information
Supplier Page
RITA
2mg
| ≥99%
CSNpharm
RITA
5mg
| ≥99%
CSNpharm
RITA
50mg
| ≥99%
CSNpharm
RITA
10mg
| ≥99%
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Rivaroxaban is an inhibitor of factor Xa (FXa) with IC50 of 0.7 nM and Ki of 0.4 nM which developmented for the treatment of thrombotic disease.
More Information
Supplier Page
CSNpharm
Rivaroxaban is an inhibitor of factor Xa (FXa) with IC50 of 0.7 nM and Ki of 0.4 nM which developmented for the treatment of thrombotic disease.
More Information
Supplier Page
CSNpharm
Rivaroxaban is an inhibitor of factor Xa (FXa) with IC50 of 0.7 nM and Ki of 0.4 nM which developmented for the treatment of thrombotic disease.
More Information
Supplier Page
CSNpharm
Rivaroxaban is an inhibitor of factor Xa (FXa) with IC50 of 0.7 nM and Ki of 0.4 nM which developmented for the treatment of thrombotic disease.
More Information
Supplier Page
CSNpharm
Rivastigmine is a acetylcholinesterase inhibitor with IC50 value of 5.5 μM for cholinesterase, used for the treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease.
More Information
Supplier Page
CSNpharm
Rivastigmine is a acetylcholinesterase inhibitor with IC50 value of 5.5 μM for cholinesterase, used for the treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease.
More Information
Supplier Page
CSNpharm
Rivastigmine is a acetylcholinesterase inhibitor with IC50 value of 5.5 μM for cholinesterase, used for the treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease.
More Information
Supplier Page
